Beijing Friendship Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1952-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.bfh.com.cn
Discrimination of DILI and AIH by Artificial Intelligence
Completed
- Conditions
- Drug-induced Liver InjuryAutoimmune Hepatitis
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 2583
- Registration Number
- NCT05532345
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT
Not Applicable
Recruiting
- Conditions
- Chronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome
- Interventions
- Other: donor EBV-specific T lymphocytes
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT05532826
- Locations
- 🇨🇳
Zhao Wang, Beijing, Beijing, China
Effect of Sacubitril/valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: a Real World Study
Recruiting
- Conditions
- Sacubitril/valsartanHypertensionObesity
- Interventions
- Drug: ACEI/ARB
- First Posted Date
- 2022-08-12
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT05498675
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Comparison of the Effects of Esketamine, Sufentanil, or Lidocaine on Tussis Reflection During Upper Gastroscopy
Not Applicable
Recruiting
- Conditions
- Anesthesia
- Interventions
- First Posted Date
- 2022-08-11
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT05497492
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Intracorporeal Versus Extracorporeal Anastomotic After Laparoscopic Right Colectomy
Not Applicable
Not yet recruiting
- Conditions
- Colon Cancer
- Interventions
- Procedure: Intracorporeal anastomotic after LRCProcedure: Extracorporeal anastomotic after LRC
- First Posted Date
- 2022-08-09
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 1158
- Registration Number
- NCT05493033
Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis
Phase 1
Not yet recruiting
- Conditions
- Langerhans Cell Histiocytosis
- Interventions
- Biological: CD207 CAR-T cells
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2022-07-28
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05477446
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
Clinical Indicators and Brain Image Data: a Study Based on Kailuan Cohort
Recruiting
- Conditions
- Brain DiseasesHypertension
- Interventions
- Other: No intervention will be applied.
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT05453877
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Kailuan General Hospital, Tangshan, Hebei, China
Chinese Colorectal Cancer Database
Recruiting
- Conditions
- Prospective StudiesColonic CancerRectal Cancer
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 200000
- Registration Number
- NCT05434026
- Locations
- 🇨🇳
Zhongtao Zhang, Beijing, China
Rituximab Monotherapy for EBV-HLH and CAEBV
Phase 3
- Conditions
- Secondary Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus Infection
- Interventions
- First Posted Date
- 2022-05-20
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05384743
- Locations
- 🇨🇳
Zhao Wang, Beijing, China
Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer
- Conditions
- Colorectal Neoplasms
- Interventions
- Combination Product: long course radiotherapy + capecitabine + PD-1 monoclonal antibody
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05368051
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath